Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5118)
All Articles published online
|
Mar 14, 2011 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zheng CF, Xu JH, Huang Y, Leung YK. Treatment of pediatric refractory Crohn’s disease with thalidomide. World J Gastroenterol 2011; 17(10): 1286-1291 [PMID: 21455327 DOI: 10.3748/wjg.v17.i10.1286] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i10/1286.htm |
| Number | Citing Articles |
| 1 |
Kaiyue Peng, Xiaowen Qian, Zhiheng Huang, Junping Lu, Yuhuan Wang, Ying Zhou, Huijun Wang, Bingbing Wu, Ying Wang, Lingli Chen, Xiaowen Zhai, Ying Huang. Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency. Inflammatory Bowel Diseases 2018; 24(7): 1416 doi: 10.1093/ibd/izy028
|
| 2 |
Marzia Lazzerini, Vincenzo Villanacci, Maria Chiara Pellegrin, Stefano Martelossi, Giuseppe Magazzù, Salvatore Pellegrino, Maria Cristina Lucanto, Arrigo Barabino, Angela Calvi, Serena Arrigo, Paolo Lionetti, Massimo Fontana, Giovanna Zuin, Giuseppe Maggiore, Matteo Bramuzzo, Massimo Maschio, Marianna Salemme, Stefania Manenti, Luisa Lorenzi, Giuliana Decorti, Marcella Montico, Alessandro Ventura. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide. Clinical Gastroenterology and Hepatology 2017; 15(9): 1382 doi: 10.1016/j.cgh.2017.02.029
|
| 3 |
Lin Wang, Aijuan Xue, Cuifang Zheng, Ying Zhou, Yuhuan Wang, Ying Huang. Long‐term outcomes of thalidomide in pediatric Crohn's disease. Journal of Gastroenterology and Hepatology 2020; 35(7): 1124 doi: 10.1111/jgh.14939
|
| 4 |
Antonella Diamanti, Teresa Capriati, Bronislava Papadatou, Daniela Knafelz, Fiammetta Bracci, Tiziana Corsetti, Domenica Elia, Giuliano Torre. The clinical implications of thalidomide in inflammatory bowel diseases. Expert Review of Clinical Immunology 2015; 11(6): 699 doi: 10.1586/1744666X.2015.1027687
|
| 5 |
SL Smith, P Singh, D Harding, D Lun, JP Chambers. Thalidomide pharmacokinetics in sheep. New Zealand Veterinary Journal 2016; 64(4): 238 doi: 10.1080/00480169.2015.1130663
|
| 6 |
Tingting Qiu, Huibo Li, Tong Sun, Peng Men, Xiangli Cui, Cuiwen Liu, Suodi Zhai. Thalidomide as a treatment for inflammatory bowel disease in children and adolescents: A systematic review. Journal of Clinical Pharmacy and Therapeutics 2020; 45(5): 1134 doi: 10.1111/jcpt.13196
|
| 7 |
Mario Cottone, Sara Renna, Ambrogio Orlando, Filippo Mocciaro. Medical management of Crohn's disease. Expert Opinion on Pharmacotherapy 2011; 12(16): 2505 doi: 10.1517/14656566.2011.609556
|
| 8 |
Matteo Bramuzzo, Alessandro Ventura, Stefano Martelossi, Marzia Lazzerini. Thalidomide for inflammatory bowel disease. Medicine 2016; 95(30): e4239 doi: 10.1097/MD.0000000000004239
|
| 9 |
Ying Zhou, Ying Huang. Inflammatory bowel disease in Chinese children: A retrospective analysis of 49 cases. Experimental and Therapeutic Medicine 2016; 12(5): 3363 doi: 10.3892/etm.2016.3756
|
| 10 |
Cuifang Zheng, Ying Huang, Wenhui Hu, Jieru Shi, Ziqing Ye, Xiaowen Qian, Zhiheng Huang, Aijuan Xue, Yuhuan Wang, Junping Lu, Zifei Tang, Jie Wu, Lin Wang, Kaiyue Peng, Ying Zhou, Shijian Miao, Hua Sun. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study. Inflammatory Bowel Diseases 2019; 25(4): 756 doi: 10.1093/ibd/izy289
|
| 11 |
Catherine S. Yang, Changhyun Kim, Richard J. Antaya. Review of thalidomide use in the pediatric population. Journal of the American Academy of Dermatology 2015; 72(4): 703 doi: 10.1016/j.jaad.2015.01.002
|
| 12 |
C. Yang, P. Singh, H. Singh, M.‐L. Le, W. El‐Matary. Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2015; 41(11): 1079 doi: 10.1111/apt.13181
|
| 13 |
Maria Luisa Martínez-Frías. Talidomida: 50 años después. Medicina Clínica 2012; 139(1): 25 doi: 10.1016/j.medcli.2011.10.011
|
| 14 |
Huiqin Hu, Xinying Wang, Side Liu. Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence. Medicine 2016; 95(36): e4799 doi: 10.1097/MD.0000000000004799
|
| 15 |
Jiahua Xu, Cuifang Zheng, Ying Huang, Yingjie Liang. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism. Chinese Medical Journal 2014; 127(12): 2368 doi: 10.3760/cma.j.issn.0366-6999.20133290
|
| 16 |
Andrea Affronti, Ambrogio Orlando, Mario Cottone. An update on medical management on Crohn’s disease. Expert Opinion on Pharmacotherapy 2015; 16(1): 63 doi: 10.1517/14656566.2015.981525
|
| 17 |
Zhenhua Zhu, Mengling Li, Xu Shu, Aiping Bai, Shunhua Long, Dongsheng Liu, Nonghua Lu, Xuan Zhu, Wangdi Liao. Thalidomide is a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients. Clinics and Research in Hepatology and Gastroenterology 2017; 41(2): 210 doi: 10.1016/j.clinre.2016.09.012
|
| 18 |
G. Rogler. Editorial: is thalidomide a good option for patients with refractory Crohn's disease?. Alimentary Pharmacology & Therapeutics 2015; 41(8): 785 doi: 10.1111/apt.13106
|
| 19 |
Ziqing Ye, Ying Zhou, Ying Huang, Yuhuan Wang, Junping Lu, Zifei Tang, Shijian Miao, Kuiran Dong, Zhinong Jiang. Phenotype and Management of Infantile-onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017; 23(12): 2154 doi: 10.1097/MIB.0000000000001269
|
| 20 |
Lin Wang, Yan Hong, Jie Wu, Ying-Kit Leung, Ying Huang. Efficacy of thalidomide therapy in pediatric Crohn’s disease with evidence of tuberculosis. World Journal of Gastroenterology 2017; 23(43): 7727-7734 doi: 10.3748/wjg.v23.i43.7727
|